|
DSGN
|
Design Therapeutics, Inc.
|
US
|
NASDAQ
|
|
MRNS
|
Marinus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OVID
|
Ovid Therapeutics Inc.
|
US
|
NASDAQ
|
|
SNPX
|
Synaptogenix, Inc.
|
US
|
NASDAQ
|
|
ZYNE
|
Zynerba Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NEU
|
Neuren Pharmaceuticals Ltd
|
AU
|
ASX
|
|
NURPF
|
Neuren Pharmaceutica
|
US
|
OTC
|
|
1OT
|
Ovid Therapeutics Inc
|
DE
|
F
|
|
2Y3
|
Bionano Genomics Inc
|
DE
|
F
|
|
12X1
|
Anavex Life Sciences Corp
|
DE
|
F
|
|
3AC
|
Actinogen Medical Limited
|
DE
|
F
|
|
DR6
|
ACADIA Pharmaceuticals Inc
|
DE
|
F
|
|
SH0
|
Shionogi & Co. Ltd
|
DE
|
F
|
|
ACW
|
Actinogen Medical Ltd
|
AU
|
AU
|
|
NEU
|
Neuren Pharmaceuticals Ltd
|
AU
|
AU
|
|
NMLSD
|
Restart Life Sciences Corp.
|
US
|
PINK
|